BOSTON, Mass.--(BUSINESS WIRE)--Third Rock Ventures, L.L.C., today announced the launch of the firm’s first fund with $378 million of committed capital. The fund will invest in life sciences companies at the early stages of formation.
The founding partners of Third Rock Ventures are industry veterans with a proven track record of founding and building numerous successful life sciences companies. The Third Rock team will use their first-hand operating experience to fund and launch innovative biotech and medical device companies. By effectively translating important scientific ideas into new biotech and device companies, the Third Rock team will respond to the growing demand for innovation by industry, research institutions, and patients.
